ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use

RTTNews | il y a 466
ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use

(RTTNews) - Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.

Kionex Suspension is the only commercially available therapeutically equivalent to the reference listed drug (RLD) SPS Suspension for Oral or Rectal use.

The U.S. annual sales for Sodium Polystyrene Sulfonate Oral / Rectal Suspension total approximately $30.3 million, based on March 2024 moving annual total (MAT) IQVIA data.

read more
European Shares Seen Mostly Lower Before US Inflation Data

European Shares Seen Mostly Lower Before US Inflation Data

European stocks may open broadly lower on Friday as the prospect of a peace agreement between Russia and Ukraine waned and focus shifted to a key U.S. inflation reading due later in the day that could provide additional clues on the Federal Reserve's rate outlook.
RTTNews | il y a 2h 1min
Australian Market Swings To Modest Gains In Mid-market

Australian Market Swings To Modest Gains In Mid-market

The Australian stock market is swinging to modest gains in mid-market moves on Friday after opening in the red, extending the gains in the previous two sessions, following the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 9,000 mark, with gains in energy and technology stocks partially offset by weakness in mining and financial stocks.
RTTNews | il y a 4h 5min